Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments.

The overall risk reduction (ORR) associated with cetuximab was 27%, though these results did not reach statistical significance. 66 Anti-EGFR agents may be reasonably effective, well-tolerated treatments on patients who are not eligible for standard platinum-based chemotherapy, though further trials are required to draw definitive conclusions.

also in 111,027 other papers